Pay in 4 interest-free payments of $5.56 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Dosing information Usual Adult Dose for Pernicious Anemia: Initial dose: 100 mcg intramuscularly or deep subcutaneous once a day for 6 to 7 days If clinical improvement and reticulocyte response is seen from the above dosing: 100 mcg every other day for 7 doses, then: 100 mcg every 3 to 4 days for 2 to 3 weeks, then: Maintenance dose: 100 to 1000 mcg monthly Duration of therapy: Life Comments: Administer concomitant folic acid if needed
Partnering with SYS ensures top-tier peptide expertise, advanced manufacturing, and rigorous quality assurance for research and commercial success
The endogenous protein plays crucial roles in cellular differentiation, tissue remodeling, and wound healing processes
A peptide restoring normal signaling in injured tissue is not the same as introducing it into a cancerous environment
Plasma Concentration: From ~200 ng/mL to ~80 ng/mL Research measuring GHK-Cu across different age groups has found plasma concentrations of roughly 200 ng/mL around age 20, falling to approximately 80 ng/mL by age 60 a decline of more than 50% over four decades
US$ 24.51
US$ 22.18
US$ 20.70
US$ 24.59
US$ 29.28
US$ 28.70
US$ 28.33
